FDA Inspection 651516 — Bayer AG
The FDA completed an inspection of Bayer AG on February 12, 2010 in Bergkamen. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 12, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bergkamen (Germany)